HM
Therapeutic Areas
CereMark Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| F-18 Flornaptitril (F-18 FNT) | Detection of tau and amyloid pathology for predicting progression in Mild Cognitive Impairment due to Alzheimer's Disease or Chronic Traumatic Encephalopathy | Pre-clinical / IND-enabling |